Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6557933 | 0.85 | PNMT (0.55) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7604910 | 0.83 | PNMT (0.56) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL5352660 | 0.81 | PNMT (0.50) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL5353739 | 0.80 | PNMT (0.49) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL5366733 | 0.79 | PNMT (0.72) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL29032869 | 0.79 | PNMT (0.58) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7111119 | 0.79 | PNMT (0.63) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7603814 | 0.78 | PNMT (0.70) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL9859906 | 0.78 | PNMT (0.70) | PNMTDRD2DRD4DRD3NPC1 | |
| SCHEMBL7609046 | 0.78 | PNMT (0.70) | PNMTDRD2DRD4DRD3NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0524624-B1 | Use of organometallic flurorenyl compounds. | PHILLIPS PETROLEUM CO (US) | 2002-05-15 | — | — | EP | claimed |